Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
8.42
+0.29 (3.57%)
At close: Aug 21, 2026, 4:00 PM EDT
8.45
+0.03 (0.38%)
After-hours: Aug 21, 2026, 7:30 PM EDT
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $520.72 million as of August 21, 2026. Its market cap has increased by 251.05% in one year.
Market Cap
520.72M
Enterprise Value
354.29M
1-Year Change
251.05%
Ranking
Category
Stock Price
$8.42
ChartMarket Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $520.72M, a decrease of -42.02%. That is a compound annual growth rate of -19.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 520.72M | -3.03% |
| Dec 31, 2025 | 537.02M | 232.60% |
| Dec 31, 2024 | 161.46M | -82.02% |
| Feb 8, 2024 | 898.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ARS Pharmaceuticals | 547.46M |
| Ovid Therapeutics | 546.83M |
| Artiva Biotherapeutics | 534.37M |
| Rezolute | 531.74M |
| Cabaletta Bio | 530.68M |
| MapLight Therapeutics | 519.90M |
| Evommune | 508.82M |
| BlossomHill Therapeutics | 501.94M |